≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Systemic sclerosis (FG)

Endpoint Browser

SYSTSCLE_FG

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

881

6. Filter based on genotype QC (FinnGen only)

881

Control definitions (FinnGen only)

Control exclude
RHEUMA_ENDPOINTS

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 881 728 153
Unadjusted period prevalence (%) 0.22 0.25 0.07
Median age at first event (years) 54.75 54.51 55.91

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
793
Matched controls
7928
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
323.0
481
*
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
+∞
323.0
349
*
P01BA02
ATC
hydroxychloroquine; oral
111.0
323.0
424
81
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
143.3
323.0
483
85
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
67.6
271.2
309
74
C08CA05
ATC
nifedipine; systemic
35.1
257.9
344
169
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
60.4
186.5
217
49
I73.0
ICD-10 Finland
Raynaud syndrome
75.4
180.9
203
36
M34.0
ICD-10 Finland
Progressive systemic sclerosis
+∞
156.6
145
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
154.3
143
*
XX9XE
NOMESCO Finland
Other ultrasound examination
169.6
136.2
140
10
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
14.1
120.0
218
207
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
33.6
107.7
142
51
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
295.3
103.4
103
*
XPX04
NOMESCO Finland
Angioscopy
225.7
97.8
99
5
L88
ICPC
Rheumatoid/seropositive arthritis
78.7
97.4
109
16
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.8
92.2
495
2048
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
986.2
91.7
88
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.9
88.8
392
1311
L04AX01
ATC
azathioprine; systemic
15.6
79.0
134
102
L04AA06
ATC
mycophenolic acid; systemic
30.5
77.2
104
39
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
12.5
77.2
145
139
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.7
71.6
300
903
H02AB06
ATC
prednisolone; systemic
3.9
71.6
493
2343
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
73.9
70.8
80
12
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
158.0
69.2
72
5
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
+∞
65.5
62
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
9.5
64.7
141
177
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
62.3
59
*
XG410
NOMESCO Finland
Flow-volume spirometry
11.8
62.0
119
117
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
15.9
54.8
91
64
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
14.1
54.2
95
76
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
44.9
53.8
66
16
NH3EA
NOMESCO Finland
Feet X-ray examination with load
34.7
51.7
67
21
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
141.7
50.4
53
*
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
47.1
50.2
61
14
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
7.1
49.9
130
212
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.2
48.9
384
1816
M17.1
ICD-10 Finland
Other primary gonarthrosis
9.6
47.5
101
119
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
40.8
45.7
57
15
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
462.4
44.7
44
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
44.2
42
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.7
40.3
124
249
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
4.5
38.9
151
391
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
51.6
37.0
44
9
G04BE03
ATC
sildenafil; oral
40.6
36.9
46
12
C08CA02
ATC
felodipine; oral
4.8
36.4
130
308
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
26.6
36.2
50
20
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.5
35.9
198
694
M13.9
ICD-10 Finland
Arthritis, unspecified
11.9
34.9
65
59
R06.0
ICD-10 Finland
Dyspnoea
3.0
34.3
249
1057
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
15.8
34.1
56
38
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
6.7
33.5
89
147
M34
ICD-10 Finland
Systemic sclerosis
340.5
33.1
33
*
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
16.8
32.5
52
33
E0000UV
ATC
NA
2.5
32.4
375
2081
L04AD01
ATC
ciclosporin; systemic
17.9
31.4
49
29
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
15.0
31.1
52
37
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.0
30.9
89
163
C02KX01
ATC
bosentan; oral
+∞
30.4
29
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
13.9
29.6
51
39
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
+∞
29.3
28
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.0
29.1
126
356
A02BC02
ATC
pantoprazole; systemic
2.4
28.7
550
3851
A07EC01
ATC
sulfasalazine; oral, rectal
9.7
28.7
59
65
R4120
NOMESCO Finland
Occupational therapy
5.2
28.6
93
197
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
28.6
354
1998
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
21.0
28.5
42
21
C08CA01
ATC
amlodipine; oral
2.4
28.1
314
1677
Z01.8
ICD-10 Finland
Other specified special examinations
2.7
27.2
221
982
N02AX02
ATC
tramadol; systemic, rectal
2.4
27.1
335
1873
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.3
26.8
402
2464
TGC00
NOMESCO Finland
Bronchial lavation
10.4
26.3
52
53
NF1AA
NOMESCO Finland
Hip X-ray examination
5.9
26.2
76
140
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
45.9
25.7
31
7
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
45.9
25.7
31
7
WZA10
NOMESCO Finland
Long statement of health and health related matters
18.6
25.5
39
22
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
13.2
25.1
44
35
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.8
25.0
114
336
L04AA01
ATC
[U] ciclosporin; systemic
18.4
24.1
37
21
M25.5
ICD-10 Finland
Pain in joint
2.4
24.1
249
1254
H04.10
ICD-10 Finland
Dry eye syndrome
3.3
23.6
129
436
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
23.4
195
870
J01FF01
ATC
clindamycin; systemic
2.4
23.2
257
1334
7101A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic sclerosis[SCLERODERMA]
+∞
23.0
22
*
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
31.1
22.9
30
10
SBA10
NOMESCO Finland
Measurement of excretion of saliva
19.7
22.7
34
18
L04AA13
ATC
leflunomide; oral
236.5
22.7
23
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
+∞
22.0
21
*
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
82.5
21.8
24
*
UJF32
NOMESCO Finland
Coloscopy
2.4
21.4
231
1176
A02BC01
ATC
omeprazole; systemic
2.3
21.4
248
1310
H02AB07
ATC
prednisone; oral
2.9
21.2
146
576
K74.3
ICD-10 Finland
Primary biliary cirrhosis
16.1
21.2
34
22
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
113.0
20.7
22
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
5.5
20.6
62
120
RT272
NOMESCO Finland
NA
+∞
19.9
19
*
RT172
NOMESCO Finland
NA
+∞
19.9
19
*
N03AX16
ATC
pregabalin; oral
2.4
19.8
201
988
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
107.7
19.6
21
*
M01CC01
ATC
penicillamine; oral
204.8
19.6
20
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.1
19.3
78
205
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.6
19.0
91
277
S18
ICPC
Laceration/cut
2.0
19.0
328
2039
M45
ICD-10 Finland
Ankylosing spondylitis
71.6
18.8
21
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.5
18.8
94
297
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
18.1
120
462
C03CA01
ATC
furosemide; systemic
2.2
18.1
210
1094
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
18.0
83
245
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
6.0
18.0
50
88
G73.7*M34.8
ICD-10 Finland
Myopathy in scleroderma
+∞
17.8
17
*
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
17.8
17
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
+∞
17.8
17
*
M05BA04
ATC
alendronic acid; oral
3.3
17.7
94
311
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
17.3
142
618
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
17.3
182
905
A02BC05
ATC
esomeprazole; systemic
1.9
17.3
347
2264
L99
ICPC
Musculoskeletal disease other
9.3
17.1
35
39
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.2
17.0
96
331
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.4
16.8
84
265
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
15.5
16.8
27
18
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
+∞
16.7
16
*
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
+∞
16.7
16
*
A05AA02
ATC
ursodeoxycholic acid; oral
8.2
16.7
37
47
RT160
NOMESCO Finland
NA
92.0
16.6
18
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
92.0
16.6
18
*
J01DB01
ATC
cefalexin; oral
2.1
16.5
651
5408
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.4
16.4
43
70
NG1DA
NOMESCO Finland
X-ray of knees
41.0
16.4
20
5
E000001
ATC
NA
2.2
16.2
185
950
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.1
16.1
95
336
GD1AD
NOMESCO Finland
Thorax CT examination
4.4
15.9
58
139
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
11.5
15.9
29
26
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
10.0
15.8
31
32
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
13.3
15.8
27
21
RT271
NOMESCO Finland
NA
+∞
15.7
15
*
C02KX04
ATC
macitentan; oral
86.8
15.6
17
*
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
45.9
15.1
18
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
14.9
237
1392
SPAT1263
SPAT
Sampling
1.9
14.9
343
2310
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
+∞
14.6
14
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
81.6
14.6
16
*
N02BE01
ATC
paracetamol; systemic, rectal
2.1
14.5
668
5686
RT274
NOMESCO Finland
NA
152.6
14.5
15
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
14.5
309
2022
I27.0
ICD-10 Finland
Primary pulmonary hypertension
36.8
14.5
18
5
M05BX04
ATC
denosumab; parenteral
3.8
14.4
62
173
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.4
14.4
43
83
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
14.3
114
487
ZX120
NOMESCO Finland
Intravenous
2.9
14.3
92
347
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
14.2
232
1374
A02BC03
ATC
lansoprazole; oral
1.9
14.2
246
1492
M01AC06
ATC
meloxicam; systemic, rectal
1.9
14.2
293
1891
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
54.3
13.8
16
*
B01AB05
ATC
enoxaparin; parenteral
2.0
13.7
209
1207
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
13.6
13
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
13.6
13
*
M05BA07
ATC
risedronic acid; oral
4.5
13.6
48
112
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.3
13.6
69
221
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
13.5
86
321
R13
ICD-10 Finland
Dysphagia
3.2
13.3
72
242
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
13.2
76
266
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.2
13.2
50
125
R50.9
ICD-10 Finland
Fever, unspecified
2.5
13.1
112
497
WX002
NOMESCO Finland
Sedation and analgesia
2.1
13.0
154
799
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
5.8
13.0
36
64
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
13.3
13.0
22
17
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.1
13.0
51
132
NF1DA
NOMESCO Finland
X-ray of hips
23.0
12.9
18
8
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
23.0
12.9
18
8
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
50.9
12.9
15
*
NHQ40
NOMESCO Finland
Amputation of toe
11.8
12.9
23
20
J01MA12
ATC
levofloxacin; systemic
2.1
12.9
155
809
L03.0
ICD-10 Finland
Cellulitis of finger and toe
3.2
12.8
70
236
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
12.6
310
2100
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
32.6
12.6
16
5
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
12.5
12
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
12.5
12
*
L04AB01
ATC
etanercept; parenteral
+∞
12.5
12
*
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
12.5
12
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.0
12.5
49
127
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
7.3
12.4
29
41
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
38.2
12.2
15
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
12.2
136
684
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
4.8
12.2
40
87
R15
ICD-10 Finland
Faecal incontinence
4.6
12.1
41
92
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
7.4
12.1
28
39
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
12.0
120
574
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.8
11.9
80
307
J01MA14
ATC
moxifloxacin; systemic
2.8
11.9
78
298
S97
ICPC
Chronic ulcer skin
3.9
11.8
48
128
ZXA00
NOMESCO Finland
Right side
1.9
11.7
196
1160
NDL52
NOMESCO Finland
Tenosynovectomy of hand
30.5
11.7
15
5
TEA00
NOMESCO Finland
Biopsy of lip
19.3
11.6
17
9
SPAT1254
SPAT
Administration of medicine
2.3
11.6
112
525
C02DE02
ATC
NA
10.2
11.5
22
22
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
11.5
91
384
RT231
NOMESCO Finland
NA
+∞
11.5
11
*
73409
ICD-8 Finland
Diffuse diseases of connective tissue, Sclerosis systematica NUD
+∞
11.5
11
*
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
+∞
11.5
11
*
RT310
NOMESCO Finland
NA
+∞
11.5
11
*
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
121.7
11.5
12
*
D06BX01
ATC
metronidazole; topical
2.3
11.3
113
540
J02AC01
ATC
fluconazole; systemic
1.7
11.2
364
2651
N03AX12
ATC
gabapentin; oral
2.2
11.1
114
551
SPAT1153
SPAT
Removal of sutures
1.8
11.1
232
1479
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.2
10.8
115
566
N02AA05
ATC
oxycodone; systemic
2.3
10.8
101
468
K22.7
ICD-10 Finland
Barrett oesophagus
9.0
10.8
22
25
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
10.7
535
4373
SPAT1229
SPAT
Assessment of need for aid
2.9
10.6
65
236
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
10.6
143
779
WX110
NOMESCO Finland
Local anesthesy
1.7
10.5
527
4299
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.0
10.5
41
106
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
10.5
206
1284
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
111.4
10.4
11
*
G73.7
ICD-10 Finland
Myopathy in other diseases classified elsewhere
+∞
10.4
10
*
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
16.3
10.4
16
10
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.4
10.3
90
402
L12
ICPC
Hand/finger symptom/complaint
2.2
10.3
117
589
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
10.3
135
727
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.0
10.3
58
200
L28
ICPC
Limited function/disability (L)
2.2
10.2
114
571
R4190
NOMESCO Finland
Nutritional therapy
4.1
10.1
38
95
M01AH01
ATC
celecoxib; oral (coxibs)
2.0
10.1
130
693
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
10.0
93
428
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.5
10.0
82
355
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
9.9
104
508
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.8
9.9
32
69
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
17.0
9.9
15
9
K62.3
ICD-10 Finland
Rectal prolapse
6.1
9.9
26
44
D07AC01
ATC
betamethasone; topical
1.7
9.8
261
1779
J01FA06
ATC
roxithromycin; oral
1.6
9.8
320
2311
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.3
9.8
48
151
WX320
NOMESCO Finland
Spinalanesthesy
2.0
9.8
135
740
WZA90
NOMESCO Finland
Other doctors statement
1.9
9.7
167
991
J01DA01
ATC
[U] cefalexin; systemic
1.6
9.7
484
3903
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.6
9.6
68
271
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
9.6
143
805
K22.1
ICD-10 Finland
Ulcer of oesophagus
6.5
9.6
24
38
R4110
NOMESCO Finland
Physiotherapy
1.8
9.6
197
1239
XG466
NOMESCO Finland
Sleep oxymetry
4.2
9.6
35
86
B01AF01
ATC
rivaroxaban; oral
2.8
9.5
60
224
M79.6
ICD-10 Finland
Pain in limb
1.7
9.5
267
1843
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
17.8
9.4
14
8
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
30.4
9.4
12
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
9.4
226
1492
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
9.4
9
*
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
+∞
9.4
9
*
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
+∞
9.4
9
*
M31.4
ICD-10 Finland
Aortic arch syndrome [Takayasu]
+∞
9.4
9
*
M34.2
ICD-10 Finland
Systemic sclerosis induced by drugs and chemicals
+∞
9.4
9
*
M33.2
ICD-10 Finland
Polymyositis
+∞
9.4
9
*
EBA10
NOMESCO Finland
Surgical removal of tooth
2.3
9.4
86
393
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.3
9.4
93
440
M48.0
ICD-10 Finland
Spinal stenosis
2.4
9.4
79
348
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.0
9.4
53
183
J01CA04
ATC
amoxicillin; systemic
1.7
9.3
618
5342
L95
ICPC
Osteoporosis
3.5
9.3
42
124
E000003
ATC
NA
3.4
9.3
44
135
C03DA01
ATC
spironolactone; oral
2.4
9.2
78
344
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
9.2
72
305
H03AA01
ATC
levothyroxine sodium; systemic
1.7
9.2
214
1396
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
11.6
9.1
16
14
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
9.1
254
1746
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
10.2
9.0
17
17
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
9.0
478
3872
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.6
9.0
397
3073
SFA00
NOMESCO Finland
Small filling
2.1
9.0
106
546
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
9.0
60
232
NDQ20
NOMESCO Finland
Amputation of finger
18.8
8.9
13
7
L17
ICPC
Foot/toe symptom/complaint
1.7
8.9
193
1232
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.1
8.9
47
157
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.7
8.9
60
234
SPAT1312
SPAT
General health counselling
1.7
8.8
245
1682
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
8.8
67
280
SPAT1216
SPAT
Assessment of functional ability
2.0
8.8
109
573
R60.0
ICD-10 Finland
Localized oedema
2.3
8.8
80
366
J01MA02
ATC
ciprofloxacin; systemic
1.6
8.8
269
1896
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.0
8.7
116
625
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
8.7
319
2354
L01AA01
ATC
cyclophosphamide; systemic
50.5
8.7
10
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.4
8.6
40
121
A03FA02
ATC
cisapride; oral, rectal
2.4
8.6
71
309
R51.80
ICD-10 Finland
Headache
2.0
8.6
111
590
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.5
8.6
38
111
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
16.5
8.6
13
8
RF210
NOMESCO Finland
NA
4.6
8.5
28
62
R1250
NOMESCO Finland
Evaluation of functional capability
5.2
8.5
25
49
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
6.5
8.5
21
33
E000006
ATC
NA
2.5
8.5
65
272
M13.0
ICD-10 Finland
Polyarthritis, unspecified
27.8
8.5
11
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
8.5
57
221
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
8.4
308
2266
L04AB06
ATC
golimumab; parenteral
91.0
8.4
9
*
TNG10
NOMESCO Finland
Puncture of knee
91.0
8.4
9
*
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
91.0
8.4
9
*
RT171
NOMESCO Finland
NA
91.0
8.4
9
*
A07AA02
ATC
nystatin; oral
2.6
8.4
61
248
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
8.4
184
1177
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
12.9
8.4
14
11
M01AH02
ATC
rofecoxib; oral
2.1
8.4
93
465
NH3AE
NOMESCO Finland
Feet ultrasound examination
+∞
8.3
8
*
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
+∞
8.3
8
*
M35
ICD-10 Finland
Other systemic involvement of connective tissue
+∞
8.3
8
*
M43.1
ICD-10 Finland
Spondylolisthesis
3.4
8.3
38
114
E000007
ATC
NA
2.8
8.2
52
195
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.7
8.2
55
213
S09
ICPC
Infected finger/toe
4.0
8.1
31
80
318
Kela drug reimbursment
Teriparatide
33.7
8.1
10
*
GD1UN
NOMESCO Finland
Lung circulation SPECT
17.4
8.1
12
7
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.1
8.1
43
145
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.2
8.0
41
134
RJ420
NOMESCO Finland
NA
22.3
8.0
11
5
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.9
8.0
48
175
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
8.0
245
1718
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
7.3
8.0
18
25
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.6
7.9
58
237
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.1
7.9
29
72
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
4.0
7.9
30
77
R03AC02
ATC
salbutamol; inhalant
1.5
7.9
393
3097
K59.09
ICD-10 Finland
Constipation, unspecified
2.9
7.9
47
171
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
7.9
129
750
SPAT1211
SPAT
Application of soft bandage
2.3
7.8
69
311
R02
ICPC
Shortness of breath/dyspnoea
2.1
7.8
89
449
J01AA04
ATC
lymecycline; systemic
2.0
7.8
105
568
E000002
ATC
NA
2.1
7.8
89
451
M79.7
ICD-10 Finland
Fibromyalgia
4.7
7.7
25
55
NDQ48
NOMESCO Finland
Revision or amputation or exarticulation of finger
45.4
7.7
9
*
WX111
NOMESCO Finland
Local infiltration anesthesia
45.4
7.7
9
*
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
7.7
138
827
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
7.7
75
354
ZXA05
NOMESCO Finland
Left side
1.7
7.6
170
1090
R76.0
ICD-10 Finland
Raised antibody titre
18.6
7.6
11
6
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
7.6
168
1074
NGQ20
NOMESCO Finland
Amputation of lower leg
25.3
7.6
10
*
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
5.8
7.6
20
35
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
7.5
99
531
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.1
7.5
85
431
ADA20
NOMESCO Finland
Thoracal sympathectomy
80.8
7.4
8
*
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
7.7
7.4
16
21
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.1
7.4
19
32
C08DB01
ATC
diltiazem; oral
3.0
7.4
42
146
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
13.5
7.4
12
9
SPAT1255
SPAT
Intravenous administration of medicine
2.6
7.3
51
204
286
Kela drug reimbursment
Ciclosporin eye drop
+∞
7.3
7
*
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
7.3
7
*
M32
ICD-10 Finland
Systemic lupus erythematosus
+∞
7.3
7
*
73401
ICD-8 Finland
Diffuse diseases of connective tissue, Sclerosis systematica acrosclerotica
+∞
7.3
7
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
7.3
7
*
L13
ICPC
Hip symptom/complaint
1.9
7.3
103
566
WZC30
NOMESCO Finland
Teaching
2.0
7.3
98
532
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.4
7.3
57
243
SPAT1301
SPAT
No procedures
1.6
7.2
227
1595
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
3.7
7.2
30
84
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.9
7.2
28
74
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
7.2
117
679
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
4.5
7.2
24
55
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.0
7.2
87
452
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
20.2
7.1
10
5
SPAT1325
SPAT
Vaccination
1.6
7.1
253
1832
A02BA02
ATC
ranitidine; systemic
1.7
7.1
147
921
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
12.2
7.1
12
10
A01AB09
ATC
miconazole; local oral
2.1
7.1
78
390
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
7.1
134
815
M79.1
ICD-10 Finland
Myalgia
1.9
7.1
100
553
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
7.0
99
544
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.8
6.9
27
72
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
6.9
60
269
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.1
6.9
79
402
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.4
6.9
23
53
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.8
6.9
116
681
M01AH05
ATC
etoricoxib; oral
1.5
6.8
401
3233
M10.9
ICD-10 Finland
Gout, unspecified
4.2
6.8
24
58
R4180
NOMESCO Finland
Podiatric therapy
6.8
6.8
16
24
SBB10
NOMESCO Finland
Teeth copy
2.5
6.8
49
200
J01FA10
ATC
azithromycin; systemic
1.5
6.8
442
3642
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.5
6.8
30
89
R06AE07
ATC
cetirizine; oral
1.5
6.8
331
2565
M01AX01
ATC
nabumetone; oral
3.2
6.8
34
111
M01CB01
ATC
sodium aurothiomalate; parenteral
40.4
6.8
8
*
H05AA02
ATC
teriparatide; parenteral
40.4
6.8
8
*
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
40.4
6.8
8
*
B01AC04
ATC
clopidogrel; oral
1.9
6.8
96
532
B01AX06
ATC
[U] rivaroxaban; oral
16.9
6.8
10
6
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.8
6.7
21
45
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
6.7
118
701
J01AA02
ATC
doxycycline; systemic
1.5
6.7
596
5246
L84
ICD-10 Finland
Corns and callosities
3.4
6.7
30
90
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
6.7
247
1801
GX1K5
NOMESCO Finland
Diffusion capacity
22.7
6.7
9
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
6.7
682
6216
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.8
6.7
40
147
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
6.7
401
3244
C08CA03
ATC
isradipine; systemic
6.0
6.6
17
29
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
6.0
6.6
17
29
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
3.7
6.6
27
75
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
3.9
6.6
25
65
M35.7
ICD-10 Finland
Hypermobility syndrome
12.4
6.6
11
9
H26.3
ICD-10 Finland
Drug-induced cataract
12.4
6.6
11
9
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
6.6
125
761
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.5
6.6
49
202
Z01.9
ICD-10 Finland
Special examination, unspecified
2.5
6.6
49
202
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
6.6
96
536
-1
NOMESCO Finland
NA
1.5
6.6
233
1680
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.2
6.6
61
284
GD2SN
NOMESCO Finland
Lung ventilation SPECT
10.1
6.5
12
12
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
5.4
6.5
18
34
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
6.3
6.5
16
26
M47.82
ICD-10 Finland
Other spondylosis, cervical region
3.5
6.5
28
82
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.6
6.4
27
77
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
6.4
91
501
M06
ICD-10 Finland
Other rheumatoid arthritis
70.4
6.4
7
*
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
70.4
6.4
7
*
GX1D5
NOMESCO Finland
Flow volume spirometry
70.4
6.4
7
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
70.4
6.4
7
*
NFC00
NOMESCO Finland
Exchange of a loose part of prosthesis in hip joint
70.4
6.4
7
*
L94.3
ICD-10 Finland
Sclerodactyly
70.4
6.4
7
*
ND1AE
NOMESCO Finland
Wrist ultrasound examination
70.4
6.4
7
*
L94.9
ICD-10 Finland
Localized connective tissue disorder, unspecified
70.4
6.4
7
*
WZA00
NOMESCO Finland
Short statement of of health and health related matters
2.9
6.4
37
132
K76.9
ICD-10 Finland
Liver disease, unspecified
5.0
6.4
19
39
PE1AT
NOMESCO Finland
Femoral artery PTA
8.2
6.3
13
16
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
3.2
6.3
31
100
B01AC27
ATC
selexipag; oral
+∞
6.3
6
*
RJ512
NOMESCO Finland
NA
+∞
6.3
6
*
XQ844
NOMESCO Finland
Other microscope or electron microscope examination
+∞
6.3
6
*
383
Kela drug reimbursment
Selexipag
+∞
6.3
6
*
I27.1
ICD-10 Finland
Kyphoscoliotic heart disease
+∞
6.3
6
*
H02AB04
ATC
methylprednisolone; systemic
1.8
6.2
107
631
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
5.1
6.2
18
36
UJF92
NOMESCO Finland
Capsular endoscopy
5.1
6.2
18
36
WX204
NOMESCO Finland
Axillary plexus blockaced
3.4
6.2
28
85
AA1AD
NOMESCO Finland
CT of head and brain
1.6
6.2
158
1049
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.5
6.2
20
45
N02AC04
ATC
dextropropoxyphene; oral
3.5
6.2
27
80
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.2
395
3221
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
6.1
73
376
J05AB01
ATC
aciclovir; systemic
1.6
6.1
163
1094
C01DA14
ATC
isosorbide mononitrate; oral
2.0
6.1
81
435
D02AX
ATC
Other emollients and protectives
3.2
6.1
30
97
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
12.6
6.1
10
8
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
12.6
6.1
10
8
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
3.2
6.1
29
92
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
10.1
6.0
11
11
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
6.0
180
1241
M70.2
ICD-10 Finland
Olecranon bursitis
4.2
6.0
21
51
TQW80
NOMESCO Finland
Local dermatologic skincare
3.7
6.0
24
66
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
6.1
6.0
15
25
H15.1
ICD-10 Finland
Episcleritis
5.6
6.0
16
29
K11.2
ICD-10 Finland
Sialoadenitis
3.0
6.0
32
110
M43.0
ICD-10 Finland
Spondylolysis
4.6
6.0
19
42

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015171) Extractable nuclear Ab [Units/volume] in Serum
296
192
22.71
307.65
1.7
1.1
u/ml
7.2
1.7
2.54
24
17
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
370
146
42.97
307.65
1.6
1.1
u/ml
9.5
24.5
—
24
9
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
311
161
29.31
307.65
2.5
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
344
98
56.95
307.65
1.5
1.1
u/ml
34.1
1.1
—
52
7
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
365
136
45.12
307.65
1.7
1.1
u/ml
7.7
6.4
0.14
132
19
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
365
135
45.45
307.65
1.6
1.1
u/ml
2.9
2.3
0.29
92
14
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
298
107
41.58
307.65
1.6
1.1
u/ml
36.6
37.8
—
50
9
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
270
134
28.61
307.65
2.3
1.1
g/l
0.2
0.2
3.98
258
124
(3037522) Nuclear Ab [Titer] in Serum
505
725
14.98
307.65
1.9
1.2
titre
1861.8
403.5
36.52
339
138
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
270
140
27.37
307.65
2.3
1.1
g/l
1.1
1.2
4.63
258
127
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
607
1793
8.67
221.03
4.7
2.8
ng/l
674.1
1021.2
3.13
567
1501
(3001604) Monocytes [#/volume] in Blood
776
3263
12.56
187.53
13.5
4.3
e9/l
0.6
0.6
0.38
752
2758
(3006315) Basophils [#/volume] in Blood
777
3280
12.60
186.72
13.7
4.3
e9/l
0.0
0.0
1.40
753
2774
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
114
34
38.36
182.01
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
114
34
38.36
182.01
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
114
34
38.36
182.01
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
114
34
38.36
182.01
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
114
34
38.36
182.01
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
114
34
38.36
182.01
1.4
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
781
3413
12.35
177.59
14.1
4.6
e9/l
0.2
0.2
0.16
760
2935
(3019198) Lymphocytes [#/volume] in Blood
775
3367
11.82
177.00
13.7
4.3
e9/l
1.7
2.0
7.38
753
2913
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
90
18
55.58
157.73
2.5
1.2
ug/l
8.5
8.0
0.42
90
18
(42870588) Differential panel, method unspecified - Blood
585
2130
6.20
154.82
12.8
4.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
695
2968
7.35
152.22
13.9
4.4
%
0.8
0.7
5.03
687
2743
(3019069) Monocytes/100 leukocytes in Blood
708
3086
7.59
151.15
14.6
4.6
%
9.0
8.4
6.20
700
2864
(3006504) Eosinophils/100 leukocytes in Blood
705
3064
7.51
150.90
14.0
4.4
%
3.0
2.9
0.69
697
2826
(3018010) Neutrophils/100 leukocytes in Blood
710
3134
7.52
148.37
13.5
4.3
%
58.2
56.6
3.63
700
2907
(3002030) Lymphocytes/100 leukocytes in Blood
712
3180
7.46
145.85
14.1
4.5
%
27.3
28.6
3.16
702
2940
(3013650) Neutrophils [#/volume] in Blood by Automated count
785
3995
9.86
134.33
16.7
8.2
e9/l
3.9
4.0
1.03
759
3430
(3005719) IgG [Mass/volume] in Serum or Plasma
230
423
7.01
126.37
3.4
2.8
g/l
10.3
10.3
0.05
214
373
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
524
1999
5.00
123.29
3.2
2.0
u/l
105.0
216.5
2.71
509
1883
(3023420) DNA double strand Ab [Units/volume] in Serum
85
35
26.77
121.54
2.0
1.0
iu/ml
36.7
—
—
6
0
(3004616) Nuclear Ab [Presence] in Serum
98
59
18.56
119.30
1.6
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
235
477
6.36
116.26
4.4
2.7
ng/l
113.1
168.5
1.93
226
437
(3038026) Centromere Ab [Units/volume] in Serum
85
40
23.41
115.36
1.5
1.1
u/ml
116.3
—
—
26
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
66
19
37.47
105.53
1.2
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
177
326
6.54
95.64
1.7
1.8
g/l
1.4
1.4
0.00
161
292
(3013707) Erythrocyte sedimentation rate by Westergren method
821
5144
9.75
90.09
11.6
2.9
mm/h
12.5
11.7
1.18
809
4673
(3025159) Blasts/100 leukocytes in Blood
199
445
5.48
87.00
5.7
3.7
%
0.0
1.6
0.82
42
108
(3017181) Myelocytes/100 leukocytes in Blood
211
506
5.17
84.96
5.8
3.6
%
0.7
0.9
0.49
51
149
(3002179) Metamyelocytes/100 leukocytes in Blood
202
468
5.30
84.66
5.3
3.6
%
0.4
0.7
0.82
40
101
(3021440) Promyelocytes/100 leukocytes in Blood
203
475
5.25
84.07
5.8
3.7
%
0.1
0.1
0.51
49
133
(3035350) Ketones [Presence] in Urine by Test strip
632
3352
4.13
82.61
6.0
3.3
estimate
0.0
0.0
0.00
166
593
(40760892) CBC W Ordered Manual Differential panel - Blood
379
1451
3.83
81.04
8.3
3.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
394
1569
3.73
79.00
3.6
2.3
umol/l
657.9
7464.5
6.39
357
1357
(3037467) Urinalysis macro (dipstick) panel - Urine
767
4763
5.72
78.37
8.9
3.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
630
3409
3.98
78.13
6.0
3.4
estimate
0.0
0.0
0.80
173
578
(3021601) Nitrite [Presence] in Urine by Test strip
627
3385
3.96
77.95
7.8
4.6
estimate
0.0
0.0
0.50
171
591
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
313
1081
3.94
77.35
1.4
1.2
iu/ml
39.9
19.6
1.35
134
313
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
820
5486
8.14
73.68
14.4
6.7
u/l
76.0
78.6
0.78
813
5104
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
565
2973
3.51
70.34
3.2
2.2
nmol/l
80.8
78.1
1.38
526
2652
(3006184) Hemoglobin [Mass/volume] in Capillary blood
85
103
9.03
66.10
2.0
1.9
g/l
122.8
130.3
0.96
27
78
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
85
108
8.60
63.60
1.8
1.6
iu/ml
0.1
0.2
0.27
14
19
(3013637) Mi-2 Ab [Presence] in Serum
38
12
33.05
58.68
1.3
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
38
12
33.05
58.68
1.3
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
38
12
33.05
58.68
1.3
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
38
12
33.05
58.68
1.3
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
549
3065
3.10
57.40
18.1
7.5
e9/l
0.0
0.0
0.48
504
2450
(3034770) Mitochondria Ab [Titer] in Serum
94
154
6.71
56.04
1.3
1.2
titre
1019.3
1192.5
—
14
8
(3030905) Polymorphonuclear cells [#/volume] in Blood
78
104
8.13
55.97
3.5
2.8
e9/l
3.9
4.0
0.22
78
104
(3018095) Leukocytes [#/volume] in Urine
450
2289
2.97
55.05
5.1
3.2
e6/l
55.5
89.8
0.90
314
1549
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
78
107
7.90
54.61
3.6
3.1
%
57.8
57.4
0.09
78
107
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
584
3449
3.06
53.77
8.3
6.3
mmol/l
1.2
1.2
0.62
494
2883
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
263
1024
3.24
51.12
1.3
1.2
u/ml
14.3
3.6
1.53
106
409
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
539
3116
2.88
50.36
7.5
5.5
mmol/l
1.2
1.2
0.40
500
2787
(3007164) IgA [Mass/volume] in Serum or Plasma
310
1337
3.03
50.34
1.6
1.4
g/l
2.3
2.3
0.11
206
793
(3007566) Smooth muscle Ab [Titer] in Serum
89
154
6.32
50.19
1.2
1.2
titre
82.2
65.0
—
9
10
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
89
158
6.15
48.89
1.5
1.5
titre
193.3
72.0
—
6
5
(3011397) Hemoglobin [Presence] in Urine by Test strip
337
1544
2.92
48.74
5.6
3.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
53
51
10.99
48.59
1.6
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
248
965
3.19
47.89
1.3
1.2
—
—
—
0
0
(3000492) Spirometry study
195
665
3.48
46.62
2.3
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
396
2052
2.69
44.21
4.4
3.7
ph
7.4
7.4
3.02
86
375
(3007853) Bacteria identified in Skin by Aerobe culture
187
678
3.23
40.03
2.3
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
129
372
3.89
39.28
1.7
2.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
87
185
5.11
39.15
2.4
2.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
41
37
11.57
39.13
1.7
1.1
e6/l
4101.4
17689.7
0.99
34
27
(3017143) Hepatitis C virus Ab [Presence] in Serum
171
598
3.31
38.77
1.4
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
349
1800
2.55
38.06
7.3
3.5
estimate
0.0
0.0
0.80
173
583
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
42
42
10.45
37.39
2.0
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
278
1294
2.68
37.35
3.5
2.2
e6/l
3.9
7.8
4.97
262
1133
(3022948) Iron [Moles/volume] in Serum or Plasma
227
952
2.86
37.33
3.4
2.2
umol/l
11.4
13.8
4.64
218
874
(4268621)
52
70
7.83
36.82
2.2
2.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
316
1577
2.57
36.68
3.5
1.9
mg/l
3.1
3.0
0.18
284
1301
(3030467) Casts [#/volume] in Urine by Automated count
338
1752
2.51
36.08
4.1
2.7
e6/l
0.2
0.5
2.92
286
1288
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
84
187
4.86
35.76
3.1
2.0
ug/l
118.3
1378.2
0.64
78
177
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
61
102
6.35
35.41
1.4
1.2
u/ml
5.6
5.1
0.04
25
26
(3042936) Bacteria identified in Isolate by Culture
200
804
2.92
35.40
2.8
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
142
470
3.41
34.98
1.9
3.3
g/l
65.4
66.7
0.97
131
426
(3021788) Differential panel - Synovial fluid
32
23
14.40
34.94
1.7
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
199
807
2.89
34.59
3.4
2.2
%
20.3
23.4
2.27
172
692
(36304419) Bacteria [Presence] in Urine
331
1729
2.46
34.42
4.1
2.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
440
2632
2.34
33.34
6.7
3.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
204
873
2.74
31.78
3.4
2.2
g/l
2.3
2.4
0.31
194
802
(3002582) Erythrocytes [#/volume] in Urine
347
1907
2.35
31.63
4.2
2.7
e6/l
18.2
59.0
2.87
301
1419
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
57
100
6.03
31.51
1.4
1.2
u/ml
4.2
6.8
0.39
26
37
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
192
807
2.76
30.89
1.4
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
421
2532
2.27
30.75
9.3
7.6
inr
1.1
1.2
0.90
131
746
(40758558) Short blood count panel - Blood
325
1771
2.32
29.86
11.2
6.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
227
1054
2.55
29.78
3.0
2.4
e6/l
0.7
1.4
5.41
160
560
(3024561) Albumin [Mass/volume] in Serum or Plasma
469
2980
2.23
29.56
6.2
4.3
g/l
35.4
35.9
1.29
444
2769
(3011412) CD3 cells [#/volume] in Blood
38
50
7.90
27.36
1.9
2.6
e9/l
1.0
1.0
0.08
25
28
(3041096) Erythrocytes [Presence] in Urine by Automated
328
1848
2.23
27.33
5.4
3.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
49
86
5.97
27.04
1.4
1.7
g/l
0.5
0.7
0.59
39
69
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
212
998
2.48
26.70
2.4
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
199
4.09
26.21
1.9
2.7
g/l
3.1
3.0
0.57
64
151
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
211
3.96
25.72
1.9
2.7
g/l
3.4
3.6
0.70
62
148
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
211
3.96
25.72
1.9
2.7
g/l
7.2
7.1
0.18
65
158
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
78
211
3.96
25.72
1.9
2.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
77
6.10
25.47
1.9
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
534
3702
2.12
25.40
7.7
6.2
umol/l
10.1
11.0
1.31
508
3507
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
59
130
4.79
25.33
1.9
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
293
1618
2.21
25.29
5.0
3.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
109
373
3.19
25.12
1.3
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
108
5.16
24.91
1.8
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
22
15
15.02
24.57
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
30
34
9.10
24.29
1.3
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
194
3.95
23.85
2.0
2.7
g/l
10.0
10.4
0.22
65
161
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
148
617
2.68
23.77
2.7
2.0
g/l
0.2
0.2
1.98
136
586
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
842
7238
4.69
23.49
27.7
11.4
mg/l
17.2
23.7
8.56
731
5421
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
47
91
5.40
23.38
1.6
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
146
610
2.67
23.33
1.6
2.1
nmol/l
351.2
398.1
1.32
134
559
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
286
1620
2.13
22.71
1.3
1.2
u/ml
0.5
1.4
2.03
66
433
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
63
160
4.16
22.60
2.0
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
35
8.53
22.36
1.9
2.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
46
91
5.28
22.34
1.6
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
61
154
4.18
22.06
2.0
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
21
16
13.42
22.03
1.6
1.1
e6/l
2103.7
5718.1
—
15
10
(3027135) IgG subclass 1 [Mass/volume] in Serum
35
54
6.71
21.87
1.2
1.3
g/l
8.7
6.9
0.53
26
37
(3024139) IgG subclass 3 [Mass/volume] in Serum
35
54
6.71
21.87
1.2
1.3
g/l
0.4
0.3
0.73
26
37
(3028192) IgG subclass 2 [Mass/volume] in Serum
35
54
6.71
21.87
1.2
1.3
g/l
3.0
2.7
0.33
26
37
(3027945) Reticulocytes/100 erythrocytes in Blood
152
673
2.52
21.46
2.6
2.2
%
1.9
1.8
0.36
138
605
(40768443) Skin Pathology biopsy report
87
286
3.27
21.35
1.3
1.2
—
—
—
0
0
(4062490)
35
56
6.47
21.13
1.2
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
30
41
7.54
20.88
1.9
2.2
%
14.4
12.4
0.17
12
17
(3001122) Ferritin [Mass/volume] in Serum or Plasma
446
3036
1.95
20.67
3.9
2.6
ug/l
105.5
108.2
0.09
415
2810
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
50
114
4.59
20.58
12.0
4.6
iu/ml
1649.3
332.1
0.66
16
18
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
147
666
2.45
19.66
3.1
4.6
u/l
255.6
257.2
0.03
142
630
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
113
451
2.73
19.61
2.0
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
109
430
2.75
19.34
3.7
2.7
e9/l
4.2
4.0
0.25
76
347
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
39
76
5.32
19.25
1.6
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
166
801
2.32
19.24
2.2
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
168
818
2.30
19.05
5.6
4.9
mmol/l
1.0
1.0
0.17
155
745
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
47
111
4.42
18.51
2.1
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
603
4650
1.94
18.10
6.4
4.1
e6/l
163.3
1812.9
—
9
54
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
381
2545
1.88
17.91
4.7
3.3
ng/l
24.5
45.2
0.76
268
1644
(3019150) Specific gravity of Urine by Refractometry
250
1452
2.01
17.87
7.1
3.7
kg/l
1.0
1.0
1.56
33
195
(46235355) HIV 1 and 2 tests - Meaningful Use set
192
1012
2.15
17.82
1.5
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
117
502
2.53
17.49
2.6
2.4
e9/l
71.6
71.5
0.00
94
377
(3048689) Calprotectin [Mass/mass] in Stool
166
835
2.22
17.29
1.8
2.1
ug/g
193.8
118.9
1.30
136
647
(3037692) Legionella sp identified in Specimen by Organism specific culture
20
21
9.72
17.05
1.7
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
38
81
4.86
16.95
1.3
1.5
u/ml
125.2
109.1
—
7
19
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
147
710
2.28
16.86
2.2
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
133
3.93
16.84
1.1
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
121
540
2.44
16.60
5.9
3.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
89
344
2.77
16.36
2.5
2.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
73
254
3.04
16.24
2.0
1.7
g/l
1.5
1.5
0.13
65
217
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
25
37
6.92
16.20
1.2
1.1
titre
127.1
80.0
—
7
5
(3034426) Prothrombin time (PT)
20
23
8.87
15.94
1.2
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
146
719
2.24
15.93
2.2
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
18
18
10.19
15.85
1.3
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
220
1274
1.97
15.58
4.6
3.4
ng/l
261.7
364.9
0.40
175
934
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
344
2303
1.81
15.47
4.9
3.0
u/l
30.9
33.8
0.39
331
2190
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
14
11.62
15.35
2.4
2.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
23
33
7.13
15.32
1.4
1.2
ratio
1.1
1.1
—
10
13
(3044941) Cell count panel - Synovial fluid
22
31
7.25
14.88
1.5
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
139
689
2.21
14.88
10.6
8.0
kpa
4.8
5.1
2.18
133
658
(3044889) 12 lead EKG panel
633
5106
1.85
14.78
5.6
3.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
85
340
2.66
14.60
5.9
3.0
kpa
5.2
5.2
0.24
80
322
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
327
2185
1.79
14.60
3.0
2.3
u/l
58.8
57.8
0.16
297
2005
(3021960) Folate [Moles/volume] in Serum or Plasma
251
1554
1.86
14.36
1.7
1.5
nmol/l
21.9
21.2
0.22
218
1314
(3026782) Osmolality of Urine
215
1267
1.92
14.32
3.9
2.4
mosm/kgh2o
496.8
526.9
1.49
199
1074
(3019060) Gas panel - Arterial blood
93
393
2.53
14.29
4.9
6.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
201
1163
1.94
14.12
1.8
1.7
nmol/l
1171.5
1181.0
0.05
159
866
(3003396) Base excess in Arterial blood by calculation
136
686
2.16
13.89
10.8
8.0
mmol/l
0.9
1.1
0.24
107
545
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
38
96
4.09
13.73
1.4
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
43
120
3.72
13.55
1.2
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
60
208
3.02
13.43
1.5
1.4
ug/g
292.6
299.6
0.09
32
117
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
32
72
4.57
13.40
1.5
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
13
10
13.18
13.39
1.0
1.1
%
100.4
100.7
—
13
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
10
13.18
13.39
1.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
392
2812
1.71
13.29
2.1
1.9
pmol/l
95.7
96.4
0.10
196
1366
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
42
5.85
13.26
1.1
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
40
108
3.83
13.21
1.5
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
117
570
2.21
13.00
3.8
3.3
mmol/l
1.2
1.2
0.95
108
477
(21494814) CD8 cells/100 lymphocytes in Specimen
17
21
8.23
12.79
2.4
1.8
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
16
5
32.54
12.60
1.6
1.2
%
1.4
—
—
5
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
43
127
3.51
12.48
5.2
2.8
mmol/l
24.7
25.3
0.33
37
115
(3009343) pH of Capillary blood
80
336
2.52
12.43
6.0
3.0
ph
7.4
7.4
0.18
16
42
(3023419) Bacteria identified in Sputum by Culture
33
81
4.19
12.39
3.1
3.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
174
3.11
12.37
2.3
4.1
mg/l
68.3
45.0
0.51
45
150
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
78
326
2.53
12.25
5.8
2.9
mmol/l
1.8
1.8
0.00
58
250
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
63
237
2.79
12.18
2.1
2.1
ug/l
1.2
1.0
0.17
55
209
(3013826) Glucose [Moles/volume] in Serum or Plasma
506
3942
1.67
12.13
7.1
4.4
mmol/l
6.4
6.6
1.49
487
3690
(3015377) Calcium [Moles/volume] in Serum or Plasma
354
2521
1.68
11.99
3.1
3.7
mmol/l
2.3
2.4
1.31
309
2227
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
33
85
3.99
11.64
1.2
1.4
u/ml
332.6
219.4
1.40
20
52
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
175
3.03
11.63
2.3
4.1
mg/l
27.3
56.2
0.95
43
152
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
139
758
1.99
11.42
2.6
2.5
umol/l
5.8
7.7
0.91
126
655
(3008152) Bicarbonate [Moles/volume] in Arterial blood
83
370
2.37
11.33
7.6
8.6
mmol/l
24.2
24.4
0.21
75
350
(3012095) Magnesium [Moles/volume] in Serum or Plasma
183
1099
1.84
11.22
5.1
3.3
mmol/l
0.8
0.8
0.60
167
1027
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
28
66
4.35
11.08
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
28
66
4.35
11.08
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
28
66
4.35
11.08
1.3
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
11
11.05
11.08
4.4
3.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
104
515
2.16
11.05
9.5
6.9
mmol/l
9.0
8.7
0.19
97
486
(3033658) Prothrombin time (PT) actual/Normal
259
1728
1.71
11.03
5.9
3.5
%
91.9
93.8
0.64
248
1685
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
32
6.05
10.89
2.9
3.4
%
47.2
37.4
—
9
8
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
27
63
4.39
10.82
1.3
1.1
u/l
49.2
52.6
0.20
22
44
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
63
4.39
10.82
2.7
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
313
2208
1.65
10.71
3.6
2.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
17
26
6.65
10.66
1.2
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
233
1524
1.72
10.61
2.1
1.7
mg/l
1.5
1.1
0.63
189
1146
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
45
153
3.05
10.44
1.7
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
21
41
5.22
10.35
1.7
1.4
u/l
10.4
3.3
1.14
14
20
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
32
88
3.74
10.33
2.2
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
30
79
3.90
10.28
2.2
2.7
—
—
—
0
0
(4306422)
35
103
3.50
10.23
1.3
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
99
3.53
10.10
1.2
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
109
3.40
10.08
1.2
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
92
453
2.15
9.91
2.5
2.4
au/ml
45.4
25.5
—
5
31
(40761536) Microorganisms panel - Urine sediment
110
582
2.02
9.79
6.4
3.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
16
8.23
9.75
1.2
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
41
138
3.07
9.69
1.1
1.5
—
—
—
0
0
(44790048)
29
78
3.81
9.66
2.3
1.4
—
—
—
0
0
(44790047)
29
78
3.81
9.66
2.3
1.4
—
—
—
0
0
(44806118)
29
78
3.81
9.66
2.3
1.4
—
—
—
0
0
(44790049)
29
78
3.81
9.66
2.3
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
29
5.96
9.62
1.1
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
29
5.96
9.62
1.1
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
29
5.96
9.62
1.1
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
11
10.11
9.56
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
58
237
2.55
9.56
2.4
1.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
91
455
2.12
9.42
1.4
1.2
u/ml
79.6
216.4
1.74
84
418
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
89
3.57
9.41
1.0
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
163
994
1.79
9.38
3.5
2.5
e6/l
3.0
3.7
0.33
94
502
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
84
408
2.17
9.36
1.4
1.3
au/ml
49.5
39.0
—
5
24
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
71
323
2.30
9.26
16.1
11.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
32
95
3.46
9.25
1.4
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
49
187
2.72
9.25
3.3
2.7
g/l
3.5
3.6
0.08
49
178
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
26
67
3.97
9.19
1.8
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
38
5.09
9.12
1.3
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
38
5.09
9.12
1.3
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
38
5.09
9.12
1.3
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
38
5.09
9.12
1.3
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
31
92
3.46
8.97
1.5
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
28
5.80
8.82
1.1
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
398
3078
1.53
8.72
5.3
3.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
53
218
2.52
8.63
2.0
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
681
5944
1.64
8.55
4.7
4.2
pmol/l
15.2
14.7
6.56
631
5412
(3022145) Colonoscopy Study observation
138
822
1.80
8.55
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
553
4606
1.54
8.47
3.1
2.9
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
66
303
2.27
8.44
15.4
9.4
mmol/l
24.1
24.1
0.04
55
292
(3045414) Leukocytes [Presence] in Urine
61
273
2.33
8.28
2.0
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
26
74
3.59
8.02
1.8
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
17
7.14
8.01
1.5
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
44
172
2.64
7.95
1.2
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
25
70
3.65
7.89
1.7
1.3
e6/l
2519.7
2013.1
0.18
15
45
(40767503) Oxygen content in Capillary blood by calculation
33
111
3.05
7.84
4.0
2.2
%
13.9
16.4
1.92
22
55
(3045788) Cell count panel - Pleural fluid
23
61
3.84
7.83
1.7
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
56
248
2.34
7.79
5.3
2.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
47
192
2.53
7.78
1.3
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
212
1454
1.60
7.73
1.6
1.6
pmol/l
34091370.2
17746444.9
0.19
176
1189
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
40
4.57
7.67
2.1
2.5
e6/l
1234.1
670.8
—
9
16
(3024932) HLA-DR beta [Type]
12
18
6.74
7.62
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
12
18
6.74
7.62
1.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
35
124
2.90
7.61
2.0
4.8
—
—
—
0
0
(3036489) Thrombin time
57
258
2.29
7.55
3.1
2.2
s
22.0
20.9
0.41
48
227
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
95
529
1.89
7.27
2.9
2.4
ml/min/173m2
65.9
68.3
0.22
44
217
(36660697) Celiac disease serology panel - Serum
102
582
1.85
7.24
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
22
60
3.73
7.22
1.7
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
16
6.95
7.16
3.3
8.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
18
43
4.25
7.03
2.1
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
17
6.54
6.79
1.5
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
92
519
1.86
6.76
14.0
7.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
28
94
3.04
6.70
6.0
2.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
22
64
3.50
6.60
1.7
1.3
e6/l
5909.2
39898.8
0.89
11
34
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
760
6947
1.68
6.60
5.8
4.9
mu/l
2.1
2.1
0.04
710
6351
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
123
2.75
6.57
2.6
2.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
90
3.06
6.54
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
65
3.45
6.45
1.2
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
15
6.73
6.32
2.7
8.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
22
66
3.39
6.31
1.7
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
30
4.73
6.23
2.3
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
92
533
1.81
6.22
3.7
3.6
ng/l
79.2
85.1
0.36
76
459
(3013512) EKG study
265
1995
1.47
6.09
5.5
3.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
31
4.57
6.00
2.3
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
30
113
2.71
5.88
4.9
2.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
91
2.91
5.82
1.2
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
216
1577
1.49
5.75
3.0
2.1
—
—
—
0
0
(3019225) pH of Specimen
110
687
1.69
5.72
4.7
4.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
46
3.75
5.66
2.1
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
66
3.24
5.62
3.3
4.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
531
1.75
5.46
2.5
2.4
ug/l
17.2
6.9
0.52
72
478
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
67
367
1.89
5.42
1.7
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
174
2.30
5.40
3.3
3.4
u/ml
0.4
0.4
0.06
23
102
(3044640) Blood type and Crossmatch panel - Blood
270
2084
1.43
5.32
3.2
2.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
30
4.38
5.31
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
8
11.35
5.30
1.3
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
49
3.52
5.19
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
35
4.05
5.18
2.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
34
146
2.38
5.14
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
45
219
2.11
5.07
1.9
1.6
—
—
—
0
0
(3010421) pH of Blood
34
147
2.37
5.06
5.3
3.2
ph
7.4
7.4
1.27
28
112
(40768441) Liver Pathology biopsy report
17
50
3.45
5.04
1.5
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
95
591
1.68
5.02
4.2
3.5
mmol/l
1.8
1.9
0.07
74
474
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
101
639
1.66
5.01
4.6
2.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
43
207
2.13
4.98
3.0
3.2
g/l
0.4
0.3
0.39
19
77
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
54
284
1.96
4.94
4.9
3.7
mmol/l
23.8
24.0
0.10
44
256
(3012501) Base excess in Blood by calculation
28
114
2.50
4.75
5.9
3.4
mmol/l
2.4
2.7
0.28
23
82
(3013005) Retinol [Moles/volume] in Serum or Plasma
11
25
4.44
4.57
1.5
1.5
umol/l
1.7
2.1
0.83
11
25
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
67
390
1.78
4.50
1.6
1.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
8
9
8.96
4.28
1.5
1.6
mmol/l
0.8
2.3
—
8
9
(3020961) Endomysium IgA Ab [Titer] in Serum
62
359
1.78
4.25
1.1
1.1
titre
—
146.4
—
0
8
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
63
2.90
4.08
2.7
2.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
96
635
1.57
3.99
2.4
2.2
u/l
31.4
44.6
1.73
86
538
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
753
7046
1.47
3.98
22.0
11.0
ml/min/173m2
81.0
81.1
0.05
695
5685
(3020891) Body temperature
46
248
1.90
3.96
5.7
4.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
106
2.40
3.93
1.5
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
40
207
1.98
3.88
3.0
3.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
66
401
1.70
3.84
1.5
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
89
2.51
3.82
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
60
2.87
3.81
1.2
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
18
66
2.76
3.77
1.2
2.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
54
312
1.78
3.75
3.2
2.1
e6/l
0.1
0.2
0.41
54
296
(3017817) Protein [Mass] in Urine collected for unspecified duration
16
55
2.94
3.75
1.8
2.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
19
72
2.68
3.75
3.7
3.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
16
5.67
3.66
1.9
2.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
799
7602
1.55
3.53
24.0
13.7
mmol/l
139.3
139.8
4.95
789
7364
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
26
3.88
3.53
1.1
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
26
3.88
3.53
1.1
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
13
6.20
3.50
1.3
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
13
6.20
3.50
1.3
1.0
—
—
—
0
0
(4010399)
80
524
1.58
3.49
1.7
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
178
1368
1.38
3.44
2.6
2.9
mmol/l
2.5
2.5
0.29
156
1225
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
696
0.55
3.37
1.5
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
222
2721
0.75
3.27
2.4
2.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
27
129
2.13
3.27
4.3
3.0
umol/l
35.8
37.3
0.10
21
114
(3019174) dRVVT (LA screen)
6
7
8.62
3.26
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
472
0.47
3.25
2.4
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
11
6.40
3.19
2.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
480
0.49
3.16
1.3
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
798
7628
1.49
3.02
24.2
13.8
mmol/l
3.9
3.9
0.46
787
7375
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
5
10.05
2.98
10.2
6.8
mmol/l
4.6
6.6
—
5
5
(40768446) Kidney Pathology biopsy report
8
17
4.74
2.92
1.0
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
104
750
1.44
2.90
26.6
21.2
inr
1.0
1.2
3.53
16
91
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
13
5.42
2.87
1.3
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
6
9
6.70
2.87
1.5
3.3
mg/l
8.4
8.0
—
6
9
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
9
6.70
2.87
1.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
71
2.42
2.81
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
802
7690
1.48
2.81
22.9
11.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
65
2.49
2.80
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
84
2.29
2.78
1.4
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
23
3.94
2.78
1.6
4.0
u/ml
1095.3
1297.6
—
9
23
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
85
2.26
2.72
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
85
2.26
2.72
1.4
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
15
4.69
2.60
3.3
2.9
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
26
135
1.95
2.57
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
26
135
1.95
2.57
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
46
716
0.62
2.55
1.3
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
11
5.48
2.54
3.3
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
11
5.48
2.54
1.2
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
10
33
3.05
2.53
1.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
88
2.18
2.52
1.4
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
88
2.18
2.52
1.4
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
69
2.34
2.49
2.3
2.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
26
3.49
2.48
5.1
2.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
45
2.69
2.46
1.2
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
33
190
1.77
2.40
2.2
2.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
12
5.03
2.40
2.0
9.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
28
154
1.85
2.36
1.2
1.6
e6/l
2.4
10.8
1.04
21
118
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
28
154
1.85
2.36
1.3
1.7
e6/l
473.8
745.7
0.21
22
124
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
28
3.24
2.31
2.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
85
2.14
2.30
1.1
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
23
3.50
2.27
2.1
5.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
15
66
2.29
2.25
1.2
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
9
210
0.42
2.21
1.3
4.3
u/ml
22.8
40.3
—
9
205
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
9
5.58
2.21
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
60
411
1.49
2.21
3.7
2.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
42
2.64
2.19
1.4
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
67
2.26
2.18
1.3
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
87
2.09
2.18
1.4
1.5
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
19
3.70
2.15
3.4
4.0
%
53.6
56.1
—
7
19
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
30
3.02
2.15
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
30
3.02
2.15
1.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
25
3.22
2.10
3.6
4.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
25
3.22
2.10
1.1
1.2
nmol/l
109.1
146.1
—
8
25
(40768804) Tissue Pathology biopsy report
353
3129
1.21
2.09
2.3
2.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
62
2.28
2.08
1.8
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
31
2.92
2.07
1.2
3.1
%
102.3
115.6
—
9
31
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
31
2.92
2.07
1.1
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
845
8254
1.58
1.97
40.9
17.3
e9/l
261.6
257.7
0.97
840
7996
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
21
3.35
1.97
2.7
2.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
64
2.21
1.95
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
45
2.46
1.93
1.7
2.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
71
2.13
1.93
2.7
3.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
845
8258
1.57
1.92
40.9
17.3
e12/l
4.4
4.5
8.62
839
7973
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
85
2.02
1.91
1.4
1.2
nmol/l
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
212
1.63
1.91
1.3
1.3
miu/ml
217.1
230.7
0.08
16
105
(3010813) Leukocytes [#/volume] in Blood
845
8259
1.57
1.90
40.9
17.3
e9/l
6.6
6.6
0.04
839
7976
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
158
0.38
1.90
1.3
1.4
—
—
—
0
0
(4094501)
31
189
1.66
1.89
1.2
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
28
2.87
1.86
1.3
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
31
190
1.65
1.86
5.9
3.5
mmol/l
3.9
3.8
0.62
31
182
(3045142) Bone marrow Pathology biopsy report
16
79
2.04
1.86
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
517
4788
1.19
1.82
4.2
2.9
u/l
56.4
45.0
2.28
486
4463
(3047189) Immunofixation for 24 hour Urine
8
30
2.68
1.72
1.3
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
13
3.86
1.71
1.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
90
1.91
1.66
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
135
1.72
1.63
1.3
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
130
0.38
1.63
1.2
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
14
3.59
1.61
1.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
20
3.01
1.58
1.3
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
111
896
1.27
1.55
9.0
6.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
152
1273
1.23
1.55
1.7
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
33
2.44
1.54
3.6
3.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
33
2.44
1.54
1.4
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
15
3.35
1.52
1.2
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
281
0.56
1.50
1.6
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
170
1.61
1.50
1.6
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
60
794
0.74
1.49
1.6
1.7
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
10
45
2.24
1.46
1.2
1.2
—
0.7
—
0
7
(4035726)
88
697
1.29
1.44
1.5
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
22
2.74
1.43
2.7
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
6
22
2.74
1.43
1.7
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
42
2.15
1.34
1.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
24
2.51
1.30
1.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
43
2.10
1.30
1.0
1.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
43
2.10
1.30
1.0
1.3
mmol/l
2.5
2.1
—
9
43
(4015189)
5
18
2.79
1.28
1.4
2.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
35
2.30
1.27
1.0
1.7
ug/l
6.6
9.0
—
8
28
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
211
1.49
1.27
1.4
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
77
1.83
1.26
2.3
1.9
—
—
—
0
0
(4027681)
8
36
2.23
1.24
1.4
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
171
1.54
1.24
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
22
140
1.59
1.21
2.9
2.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
31
214
1.46
1.19
1.4
1.2
—
—
—
0
0
(1002224) Polysomnography panel
20
309
0.64
1.18
1.1
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
36
0.00
1.14
0.0
2.1
—
379.0
—
0
8
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
39
287
1.38
1.08
2.1
3.4
u/ml
24.2
1251.8
1.27
31
258
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
211
1.44
1.07
1.3
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
67
1.80
1.05
1.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
46
1.97
1.03
1.1
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
46
1.97
1.03
1.1
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
64
511
1.27
1.03
1.3
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
75
1.74
1.03
1.1
1.0
u/ml
0.3
3.9
—
6
21
(1617658) Protocol used for examination of sentinel lymph nodes
5
107
0.46
1.01
1.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
12
69
1.75
0.96
1.3
1.2
pmol/l
239.3
346.6
—
7
50
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
27
2.23
0.93
1.0
3.3
u/l
184.7
196.9
—
6
27
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
145
0.55
0.93
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
145
0.55
0.93
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
146
0.54
0.93
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
146
0.54
0.93
1.1
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
142
1.49
0.93
3.9
2.8
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
70
1.72
0.93
1.1
1.1
u/ml
1.1
6.9
—
6
21
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
184
1.43
0.92
1.1
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
28
2.15
0.91
1.7
2.5
ug/l
23.5
20.0
—
6
23
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
39
297
1.33
0.91
1.4
1.5
—
—
—
0
0
(4146454)
11
64
1.73
0.86
3.6
2.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
44
1.83
0.86
2.1
3.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
31
1.94
0.84
1.0
2.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
166
0.60
0.84
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
113
0.53
0.83
2.0
1.5
—
—
—
0
0
(4034850)
34
258
1.33
0.82
8.5
9.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
105
1.53
0.82
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
248
0.68
0.81
1.2
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
31
233
1.34
0.80
1.3
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
207
1.36
0.80
1.5
2.0
u/l
2214.2
3616.7
—
9
81
(3025130) Human papilloma virus identified in Specimen
17
114
1.50
0.80
2.3
1.9
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.1
—
26.9
—
0
19
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
97
0.51
0.78
1.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
287
1.30
0.78
1.5
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
210
1919
1.12
0.76
1.4
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.1
—
51.1
—
0
6
(3009542) Hematocrit [Volume Fraction] of Blood
693
6746
1.13
0.76
29.0
13.0
%
39.1
39.4
0.54
454
4915
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
216
1980
1.12
0.74
1.5
1.6
mmol/l
1.3
1.4
0.85
175
1664
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
38
1.85
0.73
2.1
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
739
7227
1.14
0.73
4.3
4.3
mmol/l
5.6
5.9
9.18
685
6558
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
40
1.76
0.71
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
178
1619
1.12
0.70
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
45
365
1.25
0.69
1.6
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
755
7401
1.14
0.68
4.3
4.3
mmol/l
4.6
4.8
6.16
708
6833
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
61
1.65
0.68
1.4
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
27
1.86
0.68
2.4
1.8
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
42
1.67
0.68
1.1
1.5
—
62.3
—
0
6
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
60
504
1.20
0.67
1.8
3.2
pmol/l
4.2
4.5
2.40
49
445
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
103
909
1.15
0.65
4.0
4.3
%
34.3
32.9
0.62
75
582
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.2
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
29
1.73
0.64
2.8
2.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
208
1.31
0.62
1.4
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
102
0.59
0.62
1.3
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
42
344
1.23
0.61
1.6
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
749
7353
1.12
0.60
4.3
4.2
mmol/l
1.6
1.5
2.54
699
6741
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
2.3
—
2.1
—
0
13
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
35
1.72
0.57
1.5
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
42
348
1.22
0.56
4.1
3.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
116
1.39
0.54
1.1
1.1
u/ml
0.5
1.9
—
9
44
(3000764) Benzodiazepines [Presence] in Urine
15
204
0.73
0.53
1.1
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
39
1.54
0.53
1.2
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
39
1.54
0.53
1.2
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
66
1.52
0.52
1.4
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
40
1.50
0.51
1.3
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
31
251
1.24
0.51
2.1
2.1
nmol/l
12.9
12.8
0.01
25
221
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
765
7539
1.11
0.48
4.7
4.7
mmol/l
2.6
2.9
9.46
716
6921
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
102
1.38
0.47
1.4
1.0
—
11.5
—
0
9
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
68
1.48
0.47
2.4
1.8
pmol/l
159.4
201.3
—
10
63
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
48
1.46
0.47
2.0
6.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
35
416
0.83
0.45
1.5
1.3
iu/l
33.4
33.5
0.00
28
351
(3023410) Appearance of Cerebral spinal fluid
10
69
1.45
0.44
1.3
2.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
723
7113
1.09
0.44
3.9
3.8
mmol/l
1.2
1.3
3.64
676
6477
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
51
1.38
0.44
1.6
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
220
2076
1.08
0.43
3.3
3.0
mmol/l
6.4
6.9
1.21
187
1762
(3002523) Influenza virus A Ag [Presence] in Specimen
15
113
1.33
0.43
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
58
1.38
0.41
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
58
1.38
0.41
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
47
408
1.16
0.41
1.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
17
0.00
0.40
0.0
2.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
209
1974
1.08
0.40
3.4
3.1
mg/l
1360.8
339.7
0.93
130
1151
(3027008) Opiates [Presence] in Urine
16
204
0.78
0.39
1.1
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
204
0.78
0.39
1.1
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
178
1.24
0.39
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
80
1.38
0.38
1.2
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
57
640
0.88
0.37
1.8
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
202
0.79
0.37
1.1
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
188
0.79
0.33
1.1
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
87
0.69
0.33
2.0
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
103
957
1.09
0.31
1.2
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
140
0.78
0.28
1.2
1.2
—
—
—
0
0
(4024509)
8
63
1.27
0.28
2.1
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
65
1.23
0.27
1.3
1.9
ug/l
12.1
20.7
—
8
65
(3003740) Influenza virus B Ag [Presence] in Specimen
14
113
1.24
0.26
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
41
367
1.12
0.26
1.9
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
95
1.27
0.26
1.0
1.1
u/ml
1.3
0.9
—
6
37
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
85
791
1.08
0.26
2.4
4.5
ug/l
4.4
30.1
1.70
66
642
(3017315) Amylase [Enzymatic activity/volume] in Urine
5
40
1.25
0.22
1.0
1.1
u/l
132.0
576.8
—
5
34
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
107
1.22
0.21
1.2
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
1.4
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.9
—
23.7
—
0
10
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
95
897
1.07
0.21
4.6
4.4
ug/l
2.4
2.7
0.21
84
803
(3029396) Erythrocyte agglutination [Presence] in Blood
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
215
2079
1.05
0.21
4.1
3.8
mg/mmol
20.7
9.2
0.92
134
1222
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
683
6760
1.05
0.21
5.1
5.3
mmol/mol
38.5
39.5
1.13
638
6202
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
49
1.23
0.20
2.0
1.8
—
—
—
0
0
(4281824)
9
115
0.78
0.20
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
127
1.18
0.19
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
100
1.20
0.18
1.0
1.1
u/ml
0.9
3.1
—
7
47
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
60
563
1.07
0.17
1.1
1.2
iu/ml
80.6
136.4
1.05
15
217
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
32
292
1.10
0.16
1.7
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
69
1.16
0.16
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
192
0.88
0.15
4.6
4.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
77
735
1.05
0.14
3.8
4.1
%
21.1
21.8
0.17
33
334
(3023511) Choriogonadotropin [Units/volume] in Urine
9
109
0.82
0.13
1.2
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
27
248
1.09
0.13
1.7
1.6
mu/l
370.5
309.3
0.50
22
226
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
79
758
1.05
0.12
1.3
1.7
%
1.5
1.4
1.22
62
668
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
105
1.14
0.11
1.3
1.5
—
—
—
0
0
(44813793)
5
45
1.11
0.10
1.2
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
5
45
1.11
0.10
1.0
1.0
ng/l
422.2
374.3
—
5
28
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
45
1.11
0.10
1.0
1.1
—
7.3
—
0
11
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
5
46
1.09
0.09
1.0
1.0
ng/l
57.4
61.7
—
5
27
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.0
ng/l
1115.0
601.2
—
5
29
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
54
563
0.96
0.09
1.7
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
78
1.03
0.07
1.4
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
153
0.91
0.07
1.1
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
67
654
1.03
0.05
1.7
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
140
0.93
0.04
3.8
3.6
mg/l
28.7
23.3
—
7
89
(3011288) Drugs identified in Urine by Screen method
14
132
1.06
0.02
1.2
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
54
530
1.02
0.02
2.8
2.7
ug/l
0.6
0.8
0.93
30
336
(3013139) Helicobacter pylori Ag [Presence] in Stool
56
553
1.01
0.01
1.1
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
15
144
1.04
0.00
5.5
1.5
nmol/l
0.8
0.8
0.12
15
117
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
161
0.99
0.00
1.7
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
145
0.96
0.00
2.2
2.4
ug/min
31.1
139.5
—
6
94
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
4.9
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
74
0.95
0.00
1.1
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
88
0.91
0.00
1.0
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
30.7
—
0
7
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
5
50
1.00
0.00
1.4
1.1
nmol/l
365.0
411.7
—
5
43
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
90
1.00
0.00
1.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
18.6
—
0
5
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
59
1.02
0.00
1.2
2.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: SYSTSCLE_FG – Systemic sclerosis (FG)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).